The combination supports energy production, fat metabolism, and liver function
The ATTAIN-MAINTAIN trial demonstrated that patients switching from tirzepatide to orforglipron maintained most of their weight loss, with modest regain of approximately 5 kg on average
Many patients notice reduced appetite within the first week
Studies suggest it may support cellular longevity, enhance immune function, regulate circadian rhythms, and influence various cellular processes related to aging
Some of the advantages discussed with patients include enhanced recovery from injuries that affect muscles, tendons, ligaments, and other soft tissues, support for a calmer inflammatory response in irritated areas, and improved flexibility when scar tissue is limiting how you move